On February 12, 2019, Altasciences' companies (Preclinical Services in Seattle, Algorithme Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA) further united under the Altasciences brand by unveiling a new brand identity."We've spent the past 25 years partnering with our clients to research and develop potentially life-saving therapeutics," said Chris Perkin, CEO, Altasciences. "Now, our brand identity pays homage to the strength of that heritage. It not only shows who we are as a company, but where we are going."Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients' projects to help support educated, faster, and more complete early drug development decisions. Altasciences' full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. At Altasciences, we help sponsors get better drugs to the people who need them, faster. We are always available and always looking ahead — Moving in unison to deliver big impact with a personal touch.

Clinical Trials Healthy Volunteers Abuse Liability Special Populations Elderly EEG PK/PD Does Ranging & Tolerability DDI Gout Pulmonary Recreational Drug Use QT/QTc Food Effect Cardiology Proof-of-Concept Adaptive Design First-in-Human SAD/MAD Biosimilars Phase I-II Human Abuse Liability & Abuse Potential Early Cardiac Safety & TQT Smoking Adaptive Designs Proof of Concept Human Abuse Liability & Abuse Potential Early Cardiac Safety & TQT Major Drugs Pharmaceutical Preparations Pharmaceuticals